-

City of Hope Chicago Honors Cancer Survivors at Annual Celebrate Life Event

The event celebrated the life and survivorship of nearly 300 City of Hope Chicago patients

CHICAGO--(BUSINESS WIRE)--City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the U.S. and ranked among the nation’s top 5 cancer centers by U.S. News & World Report, honored the growing number of cancer survivors who have received care at City of Hope Chicago and their powerful journeys to becoming cancer free at its annual Celebrate Life® event.

For more than three decades, Celebrate Life has existed as a way of honoring the strength, determination and spirit of survivors who entrust City of Hope with their care and providing connection among this inspiring community.

This year’s event honored nearly 300 cancer survivors, both in person and virtual, celebrating five or more years since they began treatment at City of Hope Chicago, as well as the caregivers who have supported them. This important milestone was commemorated by their inclusion on the City of Hope Survivor Tree — a symbol of strength and inspiration.

“Celebrate Life embodies the steadfast spirit and determination of our survivors and serves as a poignant reminder of our commitment to our patients, our purpose and the culture of compassion that defines us — at our Chicago cancer center and beyond,” said Pete Govorchin, M.B.A., president, City of Hope Chicago. “Their resilience and courage is a beacon of hope for those grappling with cancer, and it is our greatest honor to be a part of their stories.”

For more information about Celebrate Life, visit cityofhope.org/patients/celebrate-life-2024.

About City of Hope

City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the U.S., and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.

Contacts

Cathy Ingram
847-731-1520
cathryn.ingram@coh.org

City of Hope


Release Versions

Contacts

Cathy Ingram
847-731-1520
cathryn.ingram@coh.org

More News From City of Hope

Leukemia Survivors to Meet Their Lifesaving Stem Cell Donors at City of Hope’s Annual Bone Marrow Transplant (BMT) Reunion, Celebrating Program’s 50-Year Milestone

LOS ANGELES--(BUSINESS WIRE)--At an age when most teenagers are focused on school, sports and the future, Los Angeles teenager Vaughn Wilson was fighting for his life. Diagnosed with leukemia just days after Christmas in 2022, the then‑15‑year‑old would soon rely on a bone marrow transplant — and the generosity of a donor he had never met — to survive. On May 1, Wilson, now 18, will meet his German donor for the first time at City of Hope’s BMT Reunion in Duarte – an event that coincides with a...

City of Hope and UC Berkeley Researchers Teach AI to Spot Cancer Risk by Squeezing Individual Breast Cells

LOS ANGELES--(BUSINESS WIRE)--Researchers at City of Hope®, a cancer research and treatment organization, and the University of California, Berkeley, have created a novel microfluidic platform that can assess women’s breast cancer risk at the cellular level. The first-of-its-kind platform squeezes individual breast epithelial cells, creating a taxing environment to measure how they deform, recover and behave under stress, according to a new study published today in Lancet’s eBioMedicine. Becaus...

City of Hope Scientists to Share New Findings on Cancer Risk, Immune Resistance and AI‑Driven Discovery at AACR 2026

LOS ANGELES--(BUSINESS WIRE)--Researchers from City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States with its National Medical Center ranked among the nation’s top cancer centers by U.S. News & World Report, will present new data at the AACR Annual Meeting 2026, sharing insights into cancer risk, treatment resistance and emerging therapeutic strategies across solid and blood cancers. From April 17–22, expertise from City of Hope...
Back to Newsroom